Compositions And Methods Of Use For Tyrosine Kinase Inhibitors To Treat Pathogenic Infection

Abstract

Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection. In particular, methods for using Abl-family tyrosine kinase inhibitors to treat pathogenic infection are provided. Infections to be treated according to the present invention include, particularly, those caused by microbial pathogens such as bacteria and viruses.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 1, 2014
  • Application: Dec 16, 2010
    US US 96965910 A
  • Priority: Dec 16, 2010
    US US 96965910 A
  • Priority: May 6, 2010
    US US 77482810 A
  • Priority: Sep 1, 2009
    US US 55187109 A
  • Priority: Dec 24, 2008
    US US 34376408 A
  • Priority: Jan 20, 2005
    US US 2005/0001710 W
  • Priority: Sep 29, 2004
    US US 61420304 P
  • Priority: Mar 16, 2004
    US US 55368104 P
  • Priority: Jan 21, 2004
    US US 53796004 P

Download Citation


Sign in to the Lens

Feedback